Synthetic applications of planar chiral cationic η3-allylmolybdenum complexes

Verfasser / Beitragende:
[P. Kocienski, Richard Bell, Elyse Bourque, J. A. Christopher, John Cooksey, Andrew Gunn, Alexander Kuhl, Y. Li, S. Uppal, Josephine Yuen]
Ort, Verlag, Jahr:
2004
Enthalten in:
Pure and Applied Chemistry, 76/3(2004-01-01), 477-494
Format:
Artikel (online)
Online Zugang:
Get it Online (National Licence)
ID: 378923048
LEADER caa a22 4500
001 378923048
003 CHVBK
005 20180305123610.0
007 cr unu---uuuuu
008 161128e20040101xx s 000 0 eng
024 7 0 |a 10.1351/pac200476030477  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1351/pac200476030477 
245 0 0 |a Synthetic applications of planar chiral cationic η3-allylmolybdenum complexes  |h [Elektronische Daten]  |c [P. Kocienski, Richard Bell, Elyse Bourque, J. A. Christopher, John Cooksey, Andrew Gunn, Alexander Kuhl, Y. Li, S. Uppal, Josephine Yuen] 
520 3 |a The synthesis of planar chiral η3-allylmolybdenum complexes is described together with some examples of the nucleophilic addition of organocopper(I) reagents. 
540 |a © 2013 Walter de Gruyter GmbH, Berlin/Boston 
700 1 |a Kocienski  |D P.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Bell  |D Richard  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Bourque  |D Elyse  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Christopher  |D J. A.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Cooksey  |D John  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Gunn  |D Andrew  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Kuhl  |D Alexander  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Li  |D Y.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Uppal  |D S.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
700 1 |a Yuen  |D Josephine  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
773 0 |t Pure and Applied Chemistry  |d De Gruyter  |g 76/3(2004-01-01), 477-494  |x 0033-4545  |q 76:3<477  |1 2004  |2 76  |o pac 
856 4 0 |u https://doi.org/10.1351/pac200476030477  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1351/pac200476030477  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kocienski  |D P.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bell  |D Richard  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bourque  |D Elyse  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Christopher  |D J. A.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cooksey  |D John  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gunn  |D Andrew  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kuhl  |D Alexander  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D Y.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Uppal  |D S.  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yuen  |D Josephine  |u Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Pure and Applied Chemistry  |d De Gruyter  |g 76/3(2004-01-01), 477-494  |x 0033-4545  |q 76:3<477  |1 2004  |2 76  |o pac 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter 

Verknüpfte Einträge